Your session is about to expire
← Back to Search
M-Tech Trial Summary
This trial assesses the feasibility and preliminary efficacy of a care delivery intervention in older patients with hematologic malignancies receiving outpatient chemotherapy.
M-Tech Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.M-Tech Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- There are no specific criteria for exclusion.You are able to walk a short distance of 4 meters, with or without the help of a walking aid.
- Group 1: M-Tech
- Group 2: Usual Care
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is recruitment for this experiment still ongoing?
"Clinicaltrials.gov confirms that the recruitment period for this medical trial, which was initiated on December 1st 2022 and last updated July 11th, has concluded. However, 745 other studies are actively admitting participants currently."
What objective results is this clinical trial hoping to accomplish?
"This research endeavour, which spans 4-5 months, aims to assess patient Retention rates. The secondary objectives are the Difference between experimental and active comparator arms - Functional Status (measured on a three-point Likert scale via the OARS IADL subscale), Difference between experimental and active comparator arms - Quality of Life (evaluated using FACT-G's 27 items divided into PWB, SWB EWB &FWB scales)and finally Difference between experimental and active comparator arms - Healthcare Utilization that captures hospitalizations/ER visits through medical chart review."
Share this study with friends
Copy Link
Messenger